Literature DB >> 27312544

Participation of MicroRNA-34a and RANKL on bone repair induced by poly(vinylidene-trifluoroethylene)/barium titanate membrane.

Helena B Lopes1, Emanuela P Ferraz1, Adriana L G Almeida1, Pedro Florio1, Rossano Gimenes2, Adalberto L Rosa1, Marcio M Beloti1.   

Abstract

The poly(vinylidene-trifluoroethylene)/barium titanate (PVDF) membrane enhances in vitro osteoblast differentiation and in vivo bone repair. Here, we hypothesized that this higher bone repair could be also due to bone resorption inhibition mediated by a microRNA (miR)/RANKL circuit. To test our hypothesis, the large-scale miR expression of bone tissue grown on PVDF and polytetrafluoroethylene (PTFE) membranes was evaluated to identify potential RANKL-targeted miRs modulated by PVDF. The animal model used was rat calvarial defects implanted with either PVDF or PTFE. At 4 and 8 weeks, the bone tissue grown on membranes was submitted to a large-scale analysis of miRs by microarray. The expression of miR-34a and some of its targets, including RANKL, were evaluated by real-time polimerase chain reaction and osteoclast activity was detected by tartrate-resistant acid phosphatase (TRAP) staining. Among more than 250 miRs, twelve, including miR-34a, were simultaneously higher expressed (≥2 fold) at 4 and 8 weeks on PVDF. The higher expression of miR-34a was concomitant with a reduced expression of all its evaluated targets, including RANKL. Additionally, more TRAP-positive cells were observed in bone tissue grown on PTFE compared with PVDF in both time points. In conclusion, our results suggest that the higher bone formation induced by PVDF could be, at least in part, triggered by a miR-34a increase and RANKL decrease, which may inhibit osteoclast differentiation and activity, and bone resorption.

Entities:  

Keywords:  Bone; RANKL; biomaterial; microRNA; osteoclast

Mesh:

Substances:

Year:  2016        PMID: 27312544     DOI: 10.1080/09205063.2016.1203217

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  3 in total

1.  MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.

Authors:  Wu-Xun Peng; Chuan Ye; Wen-Tao Dong; Lei-Luo Yang; Chun-Qing Wang; Ze-An Wei; Jian-Hua Wu; Qing Li; Jin Deng; Jian Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-28

2.  miR-34a promotes bone regeneration in irradiated bone defects by enhancing osteoblastic differentiation of mesenchymal stromal cells in rats.

Authors:  Huan Liu; Yan Dong; Xiaoke Feng; Liya Li; Yang Jiao; Shizhu Bai; Zhihong Feng; Hao Yu; Xuejian Li; Yimin Zhao
Journal:  Stem Cell Res Ther       Date:  2019-06-18       Impact factor: 6.832

3.  AAV-mediated delivery of osteoblast/osteoclast-regulating miRNAs for osteoporosis therapy.

Authors:  Aijaz Ahmad John; Jun Xie; Yeon-Suk Yang; Jung-Min Kim; Chujiao Lin; Hong Ma; Guangping Gao; Jae-Hyuck Shim
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-11       Impact factor: 10.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.